Understanding iDose® TR: A Breakthrough in Glaucoma Treatment thumbnail

Understanding iDose® TR: A Breakthrough in Glaucoma Treatment

Published Dec 02, 24
1 min read


iDose® TR marks a significant breakthrough in the treatment of glaucoma, providing a long-term and efficient method for managing intraocular pressure (IOP). Differing from traditional eye drops that require daily administration, iDose® TR is a small, implantable device engineered to release a controlled dispensation of treatment directly into the eye over an longer period. This innovative approach reduces the burden of constant dosing, dramatically boosting patient adherence and overall treatment results.

At Eye Center South, we are proud to offer iDose® TR as part of our holistic glaucoma care. The device is inserted during a gentle procedure, designed with your ease in mind. Once in place, it ensures a steady dose of the prescribed medication, helping to maintain stable IOP levels and safeguarding your eyesight. Patients who struggle with the demands of frequent eye drop use can find relief from this state-of-the-art treatment.



Visit for more info At Eye Center South